Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

0.62

Margin Of Safety %

30

Put/Call OI Ratio

0.41

EPS Next Q Diff

-0.57

EPS Last/This Y

EPS This/Next Y

0.5

Price

40.19

Target Price

43.05

Analyst Recom

3

Performance Q

3.26

Relative Volume

0.69

Beta

0.52

Ticker: GSK




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-25GSK37.970.520.55161380
2025-07-28GSK37.430.421.09135497
2025-07-29GSK37.680.420.22136207
2025-07-30GSK390.410.15148593
2025-07-31GSK37.150.401.19152132
2025-08-01GSK37.560.400.18152585
2025-08-04GSK37.670.410.73139032
2025-08-05GSK37.330.411.36139776
2025-08-06GSK36.780.410.62140237
2025-08-07GSK37.60.410.48140615
2025-08-08GSK37.780.410.34140864
2025-08-11GSK37.710.410.66139522
2025-08-12GSK38.230.411.21140151
2025-08-13GSK39.150.410.27140427
2025-08-14GSK39.220.410.01140804
2025-08-15GSK39.330.440.39135098
2025-08-18GSK39.080.400.5475618
2025-08-19GSK39.620.410.1977996
2025-08-20GSK40.080.400.5379311
2025-08-21GSK40.090.410.3785134
2025-08-22GSK40.190.410.2588936
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-25GSK37.971.95896.14.38
2025-07-28GSK37.46-0.45612.04.26
2025-07-29GSK37.67-0.45904.34.26
2025-07-30GSK38.97-0.46241.34.26
2025-07-31GSK37.15-15.44911.94.29
2025-08-01GSK37.56-15.45434.04.29
2025-08-04GSK37.68-9.65529.34.26
2025-08-05GSK37.32-9.65399.64.26
2025-08-06GSK36.79-9.65145.94.26
2025-08-07GSK37.58-9.65627.54.26
2025-08-08GSK37.80-9.65594.04.26
2025-08-11GSK37.72-9.65324.14.26
2025-08-12GSK38.23-9.65578.94.26
2025-08-13GSK39.13-9.65899.64.26
2025-08-14GSK39.22-9.65531.94.11
2025-08-15GSK39.33-9.65598.14.11
2025-08-18GSK39.08-9.65504.54.11
2025-08-19GSK39.62-9.65545.74.13
2025-08-20GSK40.08-9.65799.04.13
2025-08-21GSK40.09-9.65581.84.13
2025-08-22GSK40.19-9.65517.94.13
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-25GSK0-6.590.67
2025-07-28GSK0-6.480.67
2025-07-29GSK0-6.480.67
2025-07-30GSK0-6.480.67
2025-07-31GSK0-6.480.67
2025-08-01GSK0-6.480.67
2025-08-04GSK0-5.850.67
2025-08-05GSK0-5.850.67
2025-08-06GSK0-5.850.67
2025-08-07GSK0-5.850.67
2025-08-08GSK0-5.850.67
2025-08-11GSK0-5.840.67
2025-08-12GSK0-5.840.62
2025-08-13GSK0-5.840.62
2025-08-14GSK0-5.840.62
2025-08-15GSK0-5.840.62
2025-08-18GSK0-5.390.62
2025-08-19GSK0-5.390.62
2025-08-20GSK0-5.390.62
2025-08-21GSK0-5.390.62
2025-08-22GSK0-5.390.62
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

1.23

Avg. EPS Est. Current Quarter

1.17

Avg. EPS Est. Next Quarter

0.66

Insider Transactions

Institutional Transactions

-5.39

Beta

0.52

Average Sales Estimate Current Quarter

8210

Average Sales Estimate Next Quarter

8216

Fair Value

52.3

Quality Score

88

Growth Score

68

Sentiment Score

77

Actual DrawDown %

16.8

Max Drawdown 5-Year %

-39.3

Target Price

43.05

P/E

18.73

Forward P/E

8.35

PEG

2.05

P/S

1.98

P/B

4.01

P/Free Cash Flow

10.47

EPS

2.15

Average EPS Est. Cur. Y​

4.13

EPS Next Y. (Est.)

4.63

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

10.81

Relative Volume

0.69

Return on Equity vs Sector %

-1.5

Return on Equity vs Industry %

-9.9

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.17

EBIT Estimation

5517.9
GSK plc
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 68629
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in London, United Kingdom.
stock quote shares GSK – GlaxoSmithKline plc Stock Price stock today
news today GSK – GlaxoSmithKline plc stock forecast ,stock prediction 2023 2024 2025
marketwatch GSK – GlaxoSmithKline plc yahoo finance google finance
stock history GSK – GlaxoSmithKline plc invest stock market
stock prices GSK premarket after hours
ticker GSK fair value insiders trading